These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 18338492
1. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ. Tumori; 2007; 93(6):572-9. PubMed ID: 18338492 [Abstract] [Full Text] [Related]
2. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes. Teixeira da Costa Lodi C, Michelin MA, Miranda Lima MI, Murta EFC, Braga LDC, Montes L, Melo VH. Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185 [Abstract] [Full Text] [Related]
3. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ. Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648 [Abstract] [Full Text] [Related]
4. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application]. Zhong ZJ, Yang JX, Cao DY, Sun Y, Sun LL, Cheng XM, Chen J, Lang JH, Shen K. Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071 [Abstract] [Full Text] [Related]
5. Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions. Lattario F, Furtado YL, Fonseca R, Silveira FA, do Val IC, Almeida G, Carvalho MG. Int J Gynecol Cancer; 2008 Mar; 18(4):785-9. PubMed ID: 17868341 [Abstract] [Full Text] [Related]
6. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study. McCormick TM, Canedo NH, Furtado YL, Silveira FA, de Lima RJ, Rosman AD, Almeida Filho GL, Carvalho Mda G. Diagn Pathol; 2015 Jun 02; 10():59. PubMed ID: 26032781 [Abstract] [Full Text] [Related]
7. Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Spathis A, Aga E, Alepaki M, Chranioti A, Meristoudis C, Panayiotides I, Kassanos D, Karakitsos P. Infect Dis Obstet Gynecol; 2011 Jun 02; 2011():927861. PubMed ID: 21747645 [Abstract] [Full Text] [Related]
8. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions. Sun Y, Li S, Shen K, Ye S, Cao D, Yang J. Int J Clin Exp Pathol; 2015 Jun 02; 8(11):14939-45. PubMed ID: 26823825 [Abstract] [Full Text] [Related]
9. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S. Coll Antropol; 2010 Mar 02; 34(1):19-24. PubMed ID: 20432728 [Abstract] [Full Text] [Related]
10. Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion. Sun LL, Liu Y, Sun X, Pan L, Wu D, Wang YD. Chin Med J (Engl); 2018 Apr 20; 131(8):939-944. PubMed ID: 29664054 [Abstract] [Full Text] [Related]
11. Population-based case-control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology. Sun LL, Cao DY, Yang JX, Li H, Zhou XR, Song ZQ, Cheng XM, Chen J, Shen K. Arch Gynecol Obstet; 2012 May 20; 285(5):1433-9. PubMed ID: 22116316 [Abstract] [Full Text] [Related]
12. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B. Int J Gynecol Cancer; 2009 Apr 20; 19(3):321-5. PubMed ID: 19407553 [Abstract] [Full Text] [Related]
13. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue]. Xu J, Wang HL, Lu GC, Wang ZJ, Lin X, Zhou HW. Zhonghua Fu Chan Ke Za Zhi; 2007 Jun 20; 42(6):394-7. PubMed ID: 17697601 [Abstract] [Full Text] [Related]
14. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Rogeri CD, Silveira HCS, Causin RL, Villa LL, Stein MD, de Carvalho AC, Arantes LMRB, Scapulatempo-Neto C, Possati-Resende JC, Antoniazzi M, Longatto-Filho A, Fregnani JHTG. Gynecol Oncol; 2018 Sep 20; 150(3):545-551. PubMed ID: 29960712 [Abstract] [Full Text] [Related]
15. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women]. Niyazi M, Liu XW, Zhu KC. Zhonghua Zhong Liu Za Zhi; 2012 Jan 20; 34(1):31-4. PubMed ID: 22490852 [Abstract] [Full Text] [Related]
16. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Nagai Y, Maehama T, Asato T, Kanazawa K. Gynecol Oncol; 2000 Nov 20; 79(2):294-9. PubMed ID: 11063660 [Abstract] [Full Text] [Related]
17. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K. Int J Gynecol Pathol; 2004 Oct 20; 23(4):354-65. PubMed ID: 15381905 [Abstract] [Full Text] [Related]
18. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Iliopoulos D, Oikonomou P, Messinis I, Tsezou A. Oncol Rep; 2009 Jul 20; 22(1):199-204. PubMed ID: 19513524 [Abstract] [Full Text] [Related]
19. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, Chase DM, Tewari KS, Bernard HU. Virology; 2014 Jan 05; 448():314-21. PubMed ID: 24314662 [Abstract] [Full Text] [Related]
20. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, Khan Z, Koch WM, Califano JA. Clin Cancer Res; 2012 Feb 15; 18(4):1082-91. PubMed ID: 22228635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]